Annual EPS
-$316.52
+$19.66 K+98.42%
31 December 2023
Summary:
Panbela Therapeutics annual earnings per share is currently -$316.52, with the most recent change of +$19.66 thousand (+98.42%) on 31 December 2023. During the last 3 years, it has risen by +$17.78 thousand (+98.25%). PBLA annual EPS is now -100.77% below its all-time high of $41.23 thousand, reached on 31 December 2012.PBLA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.48
-$0.01-0.68%
30 September 2024
Summary:
Panbela Therapeutics quarterly earnings per share is currently -$1.48, with the most recent change of -$0.01 (-0.68%) on 30 September 2024. Over the past year, it has increased by +$12.01 (+89.03%). PBLA quarterly EPS is now -100.01% below its all-time high of $19.27 thousand, reached on 31 December 2012.PBLA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$18.72
+$52.26+73.63%
30 September 2024
Summary:
Panbela Therapeutics TTM earnings per share is currently -$18.72, with the most recent change of +$52.26 (+73.63%) on 30 September 2024. Over the past year, it has increased by +$600.42 (+96.98%). PBLA TTM EPS is now -100.05% below its all-time high of $41.23 thousand, reached on 31 December 2012.PBLA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBLA EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +89.0% | +97.0% |
| 3 y3 years | +98.3% | +100.0% | +99.9% |
| 5 y5 years | +98.6% | +100.0% | +99.9% |
PBLA EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.4% | -0.7% | +100.0% | at high | +100.0% |
| 5 y | 5 years | at high | +98.6% | -0.7% | +100.0% | at high | +100.0% |
| alltime | all time | -100.8% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Panbela Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.48(+0.7%) | -$18.72(-73.6%) |
| June 2024 | - | -$1.47(-35.5%) | -$70.98(-69.0%) |
| Mar 2024 | - | -$2.28(-83.1%) | -$228.66(-63.1%) |
| Dec 2023 | -$316.52(-98.4%) | -$13.49(-74.9%) | -$619.14(-84.6%) |
| Sept 2023 | - | -$53.74(-66.2%) | -$4013.65(-55.6%) |
| June 2023 | - | -$159.15(-59.5%) | -$9043.05(-73.8%) |
| Mar 2023 | - | -$392.76(-88.5%) | -$34.47 K(-15.1%) |
| Dec 2022 | -$19.97 K(+10.4%) | -$3408.00(-33.0%) | -$40.62 K(-6.7%) |
| Sept 2022 | - | -$5083.14(-80.1%) | -$43.53 K(+3.0%) |
| June 2022 | - | -$25.58 K(+290.8%) | -$42.28 K(+93.1%) |
| Mar 2022 | - | -$6546.43(+3.6%) | -$21.90 K(+5.7%) |
| Dec 2021 | -$18.10 K(+52.6%) | -$6317.86(+64.9%) | -$20.73 K(+24.9%) |
| Sept 2021 | - | -$3831.84(-26.4%) | -$16.60 K(-1.9%) |
| June 2021 | - | -$5204.76(-3.1%) | -$16.92 K(+28.8%) |
| Mar 2021 | - | -$5373.81(+145.5%) | -$13.14 K(-8.0%) |
| Dec 2020 | -$11.86 K(-47.2%) | -$2189.05(-47.3%) | -$14.29 K(-8.6%) |
| Sept 2020 | - | -$4156.72(+191.7%) | -$15.63 K(-5.0%) |
| June 2020 | - | -$1425.17(-78.1%) | -$16.45 K(-33.0%) |
| Mar 2020 | - | -$6514.49(+84.6%) | -$24.56 K(-3.8%) |
| Dec 2019 | -$22.46 K(-19.7%) | -$3528.99(-29.1%) | -$25.54 K(+0.1%) |
| Sept 2019 | - | -$4978.26(-47.8%) | -$25.52 K(+2.3%) |
| June 2019 | - | -$9542.02(+27.3%) | -$24.95 K(-8.4%) |
| Mar 2019 | - | -$7492.89(+113.6%) | -$27.24 K(-9.4%) |
| Dec 2018 | -$27.99 K | -$3507.11(-20.4%) | -$30.06 K(-25.0%) |
| Sept 2018 | - | -$4404.76(-62.8%) | -$40.06 K(-8.3%) |
| June 2018 | - | -$11.83 K(+14.8%) | -$43.67 K(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$10.31 K(-23.7%) | -$41.14 K(-39.3%) |
| Dec 2017 | -$64.84 K(+70.0%) | -$13.51 K(+68.4%) | -$67.74 K(-4.5%) |
| Sept 2017 | - | -$8019.74(-13.8%) | -$70.93 K(-0.1%) |
| June 2017 | - | -$9302.63(-74.8%) | -$71.02 K(+2.7%) |
| Mar 2017 | - | -$36.91 K(+121.0%) | -$69.13 K(+77.9%) |
| Dec 2016 | -$38.15 K(-4.0%) | -$16.70 K(+105.9%) | -$38.87 K(+38.6%) |
| Sept 2016 | - | -$8112.78(+9.5%) | -$28.04 K(+6.5%) |
| June 2016 | - | -$7409.09(+11.5%) | -$26.32 K(-88.1%) |
| Mar 2016 | - | -$6645.16(+13.2%) | -$221.41 K(-61.8%) |
| Dec 2015 | -$39.73 K(-93.2%) | -$5870.97(-8.2%) | -$579.93 K(-21.3%) |
| Sept 2015 | - | -$6395.16(-96.8%) | -$736.73 K(-20.0%) |
| June 2015 | - | -$202.50 K(-44.5%) | -$921.00 K(+26.5%) |
| Mar 2015 | - | -$365.17 K(+124.5%) | -$728.05 K(+90.9%) |
| Dec 2014 | -$588.50 K(+1565.4%) | -$162.67 K(-14.7%) | -$381.31 K(+71.8%) |
| Sept 2014 | - | -$190.67 K(+1895.8%) | -$222.00 K(+441.0%) |
| June 2014 | - | -$9553.50(-48.2%) | -$41.04 K(+3.6%) |
| Mar 2014 | - | -$18.43 K(+449.3%) | -$39.62 K(+15.3%) |
| Dec 2013 | -$35.34 K(-185.7%) | -$3354.50(-65.4%) | -$34.37 K(+192.5%) |
| Sept 2013 | - | -$9702.50(+19.3%) | -$11.75 K(-215.0%) |
| June 2013 | - | -$8133.83(-38.3%) | $10.22 K(-69.7%) |
| Mar 2013 | - | -$13.18 K(-168.4%) | $33.72 K(-18.2%) |
| Dec 2012 | $41.23 K(-278.9%) | $19.27 K(+57.0%) | $41.23 K(+87.7%) |
| Sept 2012 | - | $12.27 K(-20.2%) | $21.96 K(+126.5%) |
| June 2012 | - | $15.36 K(-371.1%) | $9696.33(-271.1%) |
| Mar 2012 | - | -$5668.33 | -$5668.33 |
| Dec 2011 | -$23.05 K | - | - |
FAQ
- What is Panbela Therapeutics annual earnings per share?
- What is the all time high annual EPS for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly EPS year-on-year change?
- What is Panbela Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Panbela Therapeutics?
- What is Panbela Therapeutics TTM EPS year-on-year change?
What is Panbela Therapeutics annual earnings per share?
The current annual EPS of PBLA is -$316.52
What is the all time high annual EPS for Panbela Therapeutics?
Panbela Therapeutics all-time high annual earnings per share is $41.23 K
What is Panbela Therapeutics quarterly earnings per share?
The current quarterly EPS of PBLA is -$1.48
What is the all time high quarterly EPS for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly earnings per share is $19.27 K
What is Panbela Therapeutics quarterly EPS year-on-year change?
Over the past year, PBLA quarterly earnings per share has changed by +$12.01 (+89.03%)
What is Panbela Therapeutics TTM earnings per share?
The current TTM EPS of PBLA is -$18.72
What is the all time high TTM EPS for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM earnings per share is $41.23 K
What is Panbela Therapeutics TTM EPS year-on-year change?
Over the past year, PBLA TTM earnings per share has changed by +$600.42 (+96.98%)